首页> 外文期刊>Journal of Signal Transduction >Parasite Mitogen-Activated Protein Kinases as Drug Discovery Targets to Treat Human Protozoan Pathogens
【24h】

Parasite Mitogen-Activated Protein Kinases as Drug Discovery Targets to Treat Human Protozoan Pathogens

机译:寄生虫促分裂原激活的蛋白激酶作为药物发现的目标,以治疗人类的原生动物病原体。

获取原文
           

摘要

Protozoan pathogens are a highly diverse group of unicellular organisms, several of which are significant human pathogens. One group of protozoan pathogens includes obligate intracellular parasites such as agents of malaria, leishmaniasis, babesiosis, and toxoplasmosis. The other group includes extracellular pathogens such as agents of giardiasis and amebiasis. An unfortunate unifying theme for most human protozoan pathogens is that highly effective treatments for them are generally lacking. We will review targeting protozoan mitogen-activated protein kinases (MAPKs) as a novel drug discovery approach towards developing better therapies, focusing onPlasmodia,Leishmania, andToxoplasma, about which the most is known.
机译:原生动物病原体是高度多样化的单细胞生物群,其中一些是重要的人类病原体。一组原生动物病原体包括专性的细胞内寄生虫,例如疟疾,利什曼病,巴贝虫病和弓形虫病。另一类包括细胞外病原体,例如贾第鞭毛虫病和阿米巴病。对于大多数人类原生动物病原体,不幸的统一主题是通常缺乏针对它们的高效治疗方法。我们将审查靶向原生动物促分裂原激活的蛋白激酶(MAPK),作为开发更好疗法的新型药物发现方法,重点是最著名的疟原虫,利什曼原虫和弓形虫。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号